NCT00120887View on ClinicalTrials.gov

Lupus Atherosclerosis Prevention Study

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

December 31, 2005

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

Atorvastatin

Trial Locations (1)

21205

Johns Hopkins Lupus Center 1830 E Monument Street, Ste 7500, Baltimore

Sponsors

Collaborators (1)

Lupus Research Alliance

All Listed Sponsors

collaborator

Lupus Research Alliance

OTHER

lead

Johns Hopkins University

OTHER

NCT00120887 - Lupus Atherosclerosis Prevention Study | Biotech Hunter | Biotech Hunter